About The Study: In this systematic review and meta-analysis of 122 U.S.-based COVID-19 clinical trials with 176,000 participants, female participants were underrepresented in treatment trials, Asian and Black participants were underrepresented in prevention trials, and Hispanic or Latino participants were overrepresented in treatment trials. Strategies to better ensure diverse representation in COVID-19 studies are needed, especially for prevention trials.
Authors: Hong Xiao, Ph.D., and Joseph M. Unger, Ph.D., M.S., of the Fred Hutchinson Cancer Center in Seattle, are the corresponding authors.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamainternmed.2022.5600)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2022.5600?guestAccessKey=f0dd0f81-7e13-48cd-a5bf-b6d57b15e1e3&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=120522
Journal
JAMA Internal Medicine